| Bradley T Vanassche, MD | |
|
1114 Charlevoix Ave, Petoskey, MI 49770-9701 | |
| (231) 439-9700 | |
| (231) 439-9709 |
| Full Name | Bradley T Vanassche |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 34 Years |
| Location | 1114 Charlevoix Ave, Petoskey, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497775514 | NPI | - | NPPES |
| 3152928 | Medicaid | MI | |
| P00957391 | Other | MI | RR MEDICARE PTAN |
| 300Z460020 | Other | MI | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301055847 (Michigan) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | BV055847 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center - Alpena | Alpena, MI | Hospital |
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Midmichigan Medical Center-clare | Clare, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Radiology Services Pc | 4284546516 | 235 |
News Archive
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.
Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.
Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus' Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.
› Verified 6 days ago
| Entity Name | Advanced Radiology Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740283324 PECOS PAC ID: 4284546516 Enrollment ID: O20031104000494 |
News Archive
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.
Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.
Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus' Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.
› Verified 6 days ago
| Entity Name | Mymichigan Medical Center Sault |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699832279 PECOS PAC ID: 7315936481 Enrollment ID: O20040512000662 |
News Archive
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.
Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.
Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus' Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.
› Verified 6 days ago
| Entity Name | Cedar Straits Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568656932 PECOS PAC ID: 3577591395 Enrollment ID: O20050802000439 |
News Archive
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.
Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.
Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus' Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.
› Verified 6 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20191106001408 |
News Archive
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.
Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.
Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus' Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bradley T Vanassche, MD 1114 Charlevoix Ave, Petoskey, MI 49770-9701 Ph: (231) 439-9700 | Bradley T Vanassche, MD 1114 Charlevoix Ave, Petoskey, MI 49770-9701 Ph: (231) 439-9700 |
News Archive
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.
Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.
Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus' Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.
› Verified 6 days ago
Dr. Nel Rainier Go, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 416 Connable Ave, Petoskey, MI 49770 Phone: 231-487-4289 | |
Michael A Angileri, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 416 Connable Ave, Petoskey, MI 49770 Phone: 231-487-4000 | |
William E Henry, MD Radiology Medicare: Medicare Enrolled Practice Location: 416 Connable Ave, Petoskey, MI 49770 Phone: 231-487-4000 | |
Dr. Matthew L Visconti, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1114 Charlevoix Ave, Petoskey, MI 49770 Phone: 231-439-9700 Fax: 231-439-9709 | |
Dr. Peter Scott Armstrong, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 416 Connable Ave, Petoskey, MI 49770 Phone: 231-487-4209 Fax: 231-487-7840 | |
William K Riordan, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 416 Connable Ave, Petoskey, MI 49770 Phone: 231-487-4000 |